Period Ending | Mar 30, 2013 | Dec 29, 2012 |
---|
Total Revenue
|
4,546,000
|
4,494,000
| Cost of Revenue | 3,043,000 | 3,360,000 | |
Gross Profit
|
1,503,000
|
1,134,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 632,000 | 871,000 |
|
Non Recurring | 62,000 | (15,000) |
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
809,000
|
278,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
|
Earnings Before Interest And Taxes | 809,000 | 278,000 |
|
Interest Expense | 123,000 | 129,000 |
|
Income Before Tax | 686,000 | 149,000 |
|
Income Tax Expense | 230,000 | 48,000 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 456,000 | 101,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
456,000
|
101,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
456,000
|
101,000
|
|